Literature DB >> 6815417

Glucose and insulin effects on the novo amino acid synthesis in young men: studies with stable isotope labeled alanine, glycine, leucine, and lysine.

J J Robert, D M Bier, X H Zhao, D E Matthews, V R Young.   

Abstract

We have explored interrelationships between te dynamic aspects of whole body glucose and alanine and glycine metabolism in adult humans. Using a primed, continuous intravenous infusion of [1-13C] leucine or lysine given simultaneously with [2H3] or [15N]alanine or [15N]glycine, respectively, whole body alanine and glycine fluxes and their rates of de novo synthesis were determined in three experiments with healthy young men. Subjects were studied in the post-absorptive state and during a 150 min period of an intravenous infusion with unlabeled glucose, at a rate of 4 mg.kg-1 min-1. In one experiment, insulin was given together with the glucose infusion to maintain normoglycemia. In the other two studies, subjects received glucose alone. For the post-absorptive state, alanine flux (mean +/- SEM) was 381 +/- 26 and 317 +/- 18 mumole.kg-1 hr-1 in two separate experiments and glycine flux was 240 +/- 22 mumole.kg-1 hr-1. De novo synthesis of alanine and glycine accounted for 75%-81% and 81% of flux, respectively. Infusion with glucose alone raised plasma glucose to a mean level of 152 mg/dl and increased alanine flux, due to a rise in alanine synthesis of 98 mumole.kg-1 hr-1 (p less than 0.01). Glycine flux and synthesis rate were unaffected by the glucose infusion. When insulin was given with glucose to maintain normoglycemia, the rate of alanine synthesis was unchanged. Because glucose uptake rate, measured with [6,6-2H2] glucose was the same whether glucose was infused along or with exogenous insulin, these results support the view that the circulating plasma glucose level itself may affect alanine synthesis and that the hyperglycemic state is an important factor in regulating interorgan nitrogen transfer, via alanine, in various pathophysiologic states.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6815417     DOI: 10.1016/0026-0495(82)90006-3

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  20 in total

Review 1.  Protein-sparing therapy in the postoperative period.

Authors:  U Keller; D Clerc; M Kränzlin; M Heberer
Journal:  World J Surg       Date:  1986-02       Impact factor: 3.352

2.  Alterations in alanine metabolism in diabetic dogs during short-term treatment with an artificial B cell.

Authors:  E J Freyse; U Fischer; G Albrecht; E Salzsieder
Journal:  Diabetologia       Date:  1985-10       Impact factor: 10.122

3.  Intravenous glucose suppresses glucose production but not proteolysis in extremely premature newborns.

Authors:  D E Hertz; C A Karn; Y M Liu; E A Liechty; S C Denne
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

Review 4.  Nutrient interactions with reference to amino acid and protein metabolism in non-ruminants; particular emphasis on protein-energy relations in man.

Authors:  V R Young
Journal:  Z Ernahrungswiss       Date:  1991-12

5.  Glycine and urea kinetics in nonalcoholic steatohepatitis in human: effect of intralipid infusion.

Authors:  Srinivasan Dasarathy; Takhar Kasumov; John M Edmison; Lourdes L Gruca; Carole Bennett; Clarita Duenas; Susan Marczewski; Arthur J McCullough; Richard W Hanson; Satish C Kalhan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-07-01       Impact factor: 4.052

6.  Insulin-mediated reduction of whole body protein breakdown. Dose-response effects on leucine metabolism in postabsorptive men.

Authors:  N K Fukagawa; K L Minaker; J W Rowe; M N Goodman; D E Matthews; D M Bier; V R Young
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

7.  Differential effects of hyperinsulinemia and hyperaminoacidemia on leucine-carbon metabolism in vivo. Evidence for distinct mechanisms in regulation of net amino acid deposition.

Authors:  P Tessari; S Inchiostro; G Biolo; R Trevisan; G Fantin; M C Marescotti; E Iori; A Tiengo; G Crepaldi
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

8.  Glycine turnover and decarboxylation rate quantified in healthy men and women using primed, constant infusions of [1,2-(13)C2]glycine and [(2)H3]leucine.

Authors:  Yvonne Lamers; Jerry Williamson; Lesa R Gilbert; Peter W Stacpoole; Jesse F Gregory
Journal:  J Nutr       Date:  2007-12       Impact factor: 4.798

9.  Gluconeogenesis from glycine and serine in fasted normal and diabetic rats.

Authors:  G Hetenyi; P J Anderson; M Raman; C Ferrarotto
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

10.  Defective suppression by insulin of leucine-carbon appearance and oxidation in type 1, insulin-dependent diabetes mellitus. Evidence for insulin resistance involving glucose and amino acid metabolism.

Authors:  P Tessari; R Nosadini; R Trevisan; S V De Kreutzenberg; S Inchiostro; E Duner; G Biolo; M C Marescotti; A Tiengo; G Crepaldi
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.